2. Search Result
Search Result
Results for "

ERAP2

" in MedChemExpress (MCE) Product Catalog:

10

Inhibitors & Agonists

1

Recombinant Proteins

1

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-150504
    ERAP2-IN-1
    1 Publications Verification

    		 Aminopeptidase Inflammation/Immunology
    ERAP2-IN-1 (compound 61) is an uncompetitive ERAP2 inhibitor. ERAP2-IN-1 specifically inhibits the ERAP2 peptide hydrolysis activity, inhibiting Arg-AMC hydrolysis with an IC50 of 27 μM and model peptide hydrolysis with an IC50 of 44 μM .
    ERAP2-IN-1
  • HY-176778
    BDM88951

    		Aminopeptidase Inflammation/Immunology Cancer
    BDM88951 (Compound 4 d) is a selective ERAP2 inhibitor with an IC50 of 19  nM. BDM88951 significantly inhibits antigen presentation. BDM88951 can be used for autoimmune diseases and cancers research .
    BDM88951
  • HY-139907B
    DG013A formate

    		Aminopeptidase Inflammation/Immunology Cancer
    DG013A (formate) is a phosphinic acid tripeptide mimetic inhibitor. DG013A (formate) displays significantly weak affinity for both ERAP1 (IC50=33 nM) and ERAP2 (IC50=11 nM). DG013A (formate) can be used for the research of autoimmune disease and cancer .
    DG013A formate
  • HY-RS04464
    ERAP2 Human Pre-designed siRNA Set A

    		Small Interfering RNA (siRNA) Others

    ERAP2 Human Pre-designed siRNA Set A contains three designed siRNAs for ERAP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    ERAP2 Human Pre-designed siRNA Set A
    ERAP2 Human Pre-designed siRNA Set A
  • HY-139907
    DG013A

    		Aminopeptidase Inflammation/Immunology Cancer
    DG013A is a phosphinic acid tripeptide mimetic inhibitor. DG013A displays significantly weak affinity for both ERAP1 (IC50=33 nM) and ERAP2 (IC50=11 nM). DG013A can be used for the research of autoimmune disease and cancer .
    DG013A
  • HY-139907A
    DG013B

    		Aminopeptidase Others
    DG013B is an epimer of DG013A (HY-139907). DG013B has weak affinity for ERAP1 and ERAP2 and is often used as a negative control to study the binding properties of DG013A and its analogues to ERAP1 and ERAP2 .
    DG013B
  • HY-139907C
    DG013B formate

    		Aminopeptidase Others
    DG013B formate is an epimer of DG013A (HY-139907). DG013B formate has weak affinity for ERAP1 and ERAP2 and is often used as a negative control to study the binding properties of DG013A and its analogues to ERAP1 and ERAP2 .
    DG013B formate
  • HY-173022
    BDM_92499

    		Aminopeptidase Others
    BDM_92499 is a nanomolar selective IRAP inhibitor, with an IC50 of 3.4 nM. BDM_92499 also inhibits ERAP1 and ERAP2, with IC50 values of 0.46 μM and 4.2 μM, respectively .
    BDM_92499
  • HY-176778A
    (rac)-BDM88951

    		Aminopeptidase Inflammation/Immunology Cancer
    (rac)-BDM88951 is the racemate of BDM88951 (HY-176778). BDM88951 (Compound 4 d) is a selective ERAP2 inhibitor with an IC50 of 19 nM. BDM88951 significantly inhibits antigen presentation in HEK cells. BDM88951 can be used for research on autoimmune diseases and cancer .
    (rac)-BDM88951
  • HY-179625
    GSK235

    		Aminopeptidase Inflammation/Immunology Cancer
    GSK235 is an orally active, selective and allosteric endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitor with pIC50 values of 8.45 and 7.59 for human and mouse ERAP1, respectively. GSK235 exhibits over 1000-fold selectivity for the two most homologous enzymes, ERAP2 and IRAP. GSK235 can regulate the immunopeptidome of cancer cells and enhance cancer cell antigenicity. GSK235 can be used for the study of colorectal cancer and arthritis .
    GSK235

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: